Summary

Type 2 Diabetes - Pipeline Review, H2 2014, provides an overview of the Type 2 Diabetess therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Type 2 Diabetes, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Type 2 Diabetes and special features on late-stage and discontinued projects.

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global therapeutic landscape of Type 2 Diabetes
- The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved in the therapeutics development for Type 2 Diabetes and enlists all their major and minor projects
- The report summarizes all the dormant and discontinued pipeline projects
- A review of the Type 2 Diabetes products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
- Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- A detailed assessment of monotherapy and combination therapy pipeline projects
- Coverage of the Type 2 Diabetes pipeline on the basis of target, MoA, route of administration and molecule type
- Latest news and deals relating related to pipeline products

Browse full report @ http://www.aarkstore.com/pharmaceuticals-healthcare/60599/type-2-diabetes-pipeline-review-h2-2014

Table of Content

Introduction 9
Type 2 Diabetes Overview 10
Therapeutics Development 11
Type 2 Diabetes - Therapeutics under Development by Companies 13
Type 2 Diabetes - Therapeutics under Investigation by Universities/Institutes 31
Type 2 Diabetes - Pipeline Products Glance 33
Type 2 Diabetes - Products under Development by Companies 37
Type 2 Diabetes - Products under Investigation by Universities/Institutes 57
Type 2 Diabetes - Companies Involved in Therapeutics Development 60
Type 2 Diabetes - Therapeutics Assessment 267
Drug Profiles 293
Type 2 Diabetes - Recent Pipeline Updates 986
Type 2 Diabetes - Dormant Projects 1095
Type 2 Diabetes - Discontinued Products 1106
Type 2 Diabetes - Product Development Milestones 1111
Appendix 1119

Related Reports:

Almac Discovery Ltd. - Product Pipeline Review - 2015

Summit Corporation plc - Product Pipeline Review - 2015

Valentia Biopharma S.L. - Product Pipeline Review - 2015

Immunomic Therapeutics, Inc. - Product Pipeline Review - 2015

About Aarkstore Enterprise

Aarkstore Enterprise is a leading provider of business and financial information and solutions worldwide. We specialize in providing online market business information on market research reports, books, magazines, conference at competitive prices, and strive to provide excellent and innovative service to our customers.

Contact Details:

Aarkstore Enterprise
Phone: +91 998 729 5242
Email: enquiry@aarkstore.com
Our Website: http://www.aarkstore.com
Our Blog : http://www.aarkstore.com/blog/
Our News Section : http://www.aarkstore.com/news